The elevated presence of peritumoral FoxP3+ lymphocytes predicts improved melanoma-specific survival (MSS), and peritumoral CD8+ and tumoral FoxP3+ lymphocytes correlate with improved OS and MSS [56]. Here, CD8A is linked to melanoma.